
|Articles|August 4, 2003
States applying for waiver should beware of funding cap
Many states are applying for a waiver under the Pharmacy Plus program in order to obtain funds for a non-Medicaid seniors' drug program, but there is a long-term risk involved.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























